New approaches to thrombolytic therapy.
- 1 November 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 4 (6) , 579-585
- https://doi.org/10.1161/01.atv.4.6.579
Abstract
Tissue-type plasminogen activator (t-PA), purified from the culture fluid of a stable human melanoma cell line, is a serine protease, different from urokinase, with a molecular weight of about 70,000. It is composed of one polypeptide chain, which is converted to a two-chain molecule by limited plasmic action. Activation of plasminogen to plasmin occurs by cleavage of the Arg 560-Val 561 peptide bond. Kinetic analysis has shown that the activation obeys Michaelis-Menten kinetics and that the presence of fibrin strikingly enhances the activation rate by increasing the affinity of plasminogen for fibrin-bound t-PA. The directed action of plasmin toward fibrin in vivo, might be explained by the low Michaelis constant in the presence of fibrin (0.16 microM), which allows efficient plasminogen activation on a fibrin clot, while its high value in the absence of fibrin (65 microM) prevents efficient activation in plasma. Plasmin formed on the fibrin surface would then be protected from rapid inactivation by alph...Keywords
This publication has 39 references indexed in Scilit:
- Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys.Journal of Clinical Investigation, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Common evolutionary origin of the fibrin‐binding structures of fibronectin and tissue‐type plasminogen activatorFEBS Letters, 1983
- Adaptation of plasminogen activator sequences to known protease structuresFEBS Letters, 1983
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen ActivatorScience, 1983
- Differential proteolysis and evidence for a residue exchange in tissue plasminogen activator suggest possible association between two types of protein microheterogeneityFEBS Letters, 1983
- Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATIONJournal of Clinical Investigation, 1983
- Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cellsBiochemical and Biophysical Research Communications, 1983
- Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrinBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- Isolation of two variants of native one‐chain tissue plasminogen activatorFEBS Letters, 1982